Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Stem Cell Reviews and Reports
|
April 23, 2026
New Gene Therapy Strategy for β-Thalassemia
Dongguo Liang, Ingo G H Schmidt-Wolf, Jingjing Pu
Epigenomics
|
December 7, 2023
Histone deacetylase 6: at the interface of cancer and neurodegeneration
Jingjing Pu, Amit Sharma, Jian Hou, et al.
BMC Medical Genomics
|
November 18, 2023
Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Clinical & Translational Immunology
|
March 26, 2024
Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway
Jingjing Pu, Amit Sharma, Ting Liu, et al.
Cancer Medicine
|
December 16, 2024
Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
Kira Vordermark, JingJing Pu, Amit Sharma, et al.
European Journal of Medicinal Chemistry
|
July 5, 2026
Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma
Keyan Han, Yuqi Lin, Yu Huang, et al.
Experimental Hematology & Oncology
|
April 23, 2024
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Scientific Reports
|
January 3, 2025
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
Annika Simone Lück, Jingjing Pu, Ahmad Melhem, et al.
Experimental Hematology & Oncology
|
October 29, 2024
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Experimental Gerontology
|
January 8, 2024
The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging
Ting Liu, Na Li, Jingjing Pu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Stem Cell Reviews and Reports
|
April 23, 2026
New Gene Therapy Strategy for β-Thalassemia
Dongguo Liang, Ingo G H Schmidt-Wolf, Jingjing Pu
Epigenomics
|
December 7, 2023
Histone deacetylase 6: at the interface of cancer and neurodegeneration
Jingjing Pu, Amit Sharma, Jian Hou, et al.
BMC Medical Genomics
|
November 18, 2023
Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Clinical & Translational Immunology
|
March 26, 2024
Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine-induced killer cell efficiency in multiple myeloma via the NKG2D pathway
Jingjing Pu, Amit Sharma, Ting Liu, et al.
Cancer Medicine
|
December 16, 2024
Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
Kira Vordermark, JingJing Pu, Amit Sharma, et al.
European Journal of Medicinal Chemistry
|
July 5, 2026
Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma
Keyan Han, Yuqi Lin, Yu Huang, et al.
Experimental Hematology & Oncology
|
April 23, 2024
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Scientific Reports
|
January 3, 2025
Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
Annika Simone Lück, Jingjing Pu, Ahmad Melhem, et al.
Experimental Hematology & Oncology
|
October 29, 2024
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
Jingjing Pu, Ting Liu, Amit Sharma, et al.
Experimental Gerontology
|
January 8, 2024
The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging
Ting Liu, Na Li, Jingjing Pu, et al.
Page
of 2